Eslam E Saad (Eslam E Abd El-Fattah)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Top Venues

Journal of translational medicine

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Bethlehem A Lulseged, Malini S Ramaiyer, Rachel Michel, Eslam E Saad, Bulent Ozpolat, Mostafa A Borahay
The Role of Nanomedicine in Benign Gynecologic Disorders. Molecules (Basel, Switzerland) 29 (9) (2024)
Bethlehem A Lulseged, Malini S Ramaiyer, Rachel Michel, Eslam E Saad, Bulent Ozpolat, Mostafa A Borahay
The Role of Nanomedicine in Benign Gynecologic Disorders. Molecules (Basel, Switzerland) 29 (9) (2024)
Eslam E Saad, Amr Y Zakaria
Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management. Journal of translational medicine 20 (1) (2022)
Eslam E Saad
IDO/kynurenine pathway in cancer: possible therapeutic approaches. Journal of translational medicine 20 (1) (2022)
Sameh Saber, Eslam E Saad, Galal Yahya, Naglaa A Gobba, Abdalkareem Omar Maghmomeh, Ahmed E Khodir, Ahmed A E Mourad, Ahmed S Saad, Hager G Mohammed, Nehal A Nouh, Ahmed Shata, Noha A Amin, Magdy Abou El-Rous, Samuel Girgis, Eman El-Ahwany, Eman M Khalaf, Attalla Farag El-Kott, Ahmed M El-Baz
A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)